ROCKVILLE, Md., April 26, 2023 (GLOBE NEWSWIRE) -- OpGen (OPGN), Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback